Immunotherapy Adverse Effects

Timothy J. Brown; Ronac Mamtani; Erin M. Bange

doi:10.1001/jamaoncol.2021.5009

Immunotherapy Adverse Effects

Timothy J. Brown, Ronac Mamtani, Erin M. Bange

Research output: Contribution to journal › Comment/debate › peer-review

Original language	English (US)
Pages (from-to)	1908
Number of pages	1
Journal	JAMA Oncology
Volume	7
Issue number	12
DOIs	https://doi.org/10.1001/jamaoncol.2021.5009
State	Published - Dec 2021
Externally published	Yes

ASJC Scopus subject areas

Oncology
Cancer Research

Access to Document

10.1001/jamaoncol.2021.5009

Cite this

@article{14b81b8db574437e996b07a7281cb600,

title = "Immunotherapy Adverse Effects",

author = "Brown, {Timothy J.} and Ronac Mamtani and Bange, {Erin M.}",

note = "Funding Information: (T32-CA-009679), and Marjorie and Bryan Weingarten Fellowship Grant. Funding Information: Conflict of Interest Disclosures: Dr Brown reported grants from National Institutes of Health (T32CA009679). Dr Mamtani reported grants from Merck and personal fees from Astellas/Seagen and Flatiron Health. Dr Bange reported grant support from the 2021 ASCO Conquer Cancer Foundation Young Investigator Award (#4245), National Institutes of Health T32 Cancer Clinical Epidemiology Training Grant",

year = "2021",

month = dec,

doi = "10.1001/jamaoncol.2021.5009",

language = "English (US)",

volume = "7",

pages = "1908",

journal = "JAMA Oncology",

issn = "2374-2437",

publisher = "American Medical Association",

number = "12",

}

TY - JOUR

T1 - Immunotherapy Adverse Effects

AU - Brown, Timothy J.

AU - Mamtani, Ronac

AU - Bange, Erin M.

N1 - Funding Information: (T32-CA-009679), and Marjorie and Bryan Weingarten Fellowship Grant. Funding Information: Conflict of Interest Disclosures: Dr Brown reported grants from National Institutes of Health (T32CA009679). Dr Mamtani reported grants from Merck and personal fees from Astellas/Seagen and Flatiron Health. Dr Bange reported grant support from the 2021 ASCO Conquer Cancer Foundation Young Investigator Award (#4245), National Institutes of Health T32 Cancer Clinical Epidemiology Training Grant

PY - 2021/12

Y1 - 2021/12

UR - http://www.scopus.com/inward/record.url?scp=85118532715&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=85118532715&partnerID=8YFLogxK

U2 - 10.1001/jamaoncol.2021.5009

DO - 10.1001/jamaoncol.2021.5009

M3 - Comment/debate

C2 - 34709372

AN - SCOPUS:85118532715

SN - 2374-2437

VL - 7

SP - 1908

JO - JAMA Oncology

JF - JAMA Oncology

IS - 12

ER -

Immunotherapy Adverse Effects

ASJC Scopus subject areas

Access to Document

Other files and links

Cite this